Search Results
Found 1 results
510(k) Data Aggregation
(119 days)
The ND: YAG Laser is indicated for the treatment of: benign cutaneous lesions, such as Warts, Scars, Striae and Psoriasis; benign pigmented lesions, such as Lentigines, Nevus, and the removal of black or blue tattoos.
The ND YAG Q-switch Laser Therapy Machine is laser system which delivers laser at a wavelength 1064nm or 532nm.
The device is indicated for the treatment of: benign cutaneous lesions, such as Warts, Scars, Striae and Psoriasis; benign pigmented lesions, such as Lentigines, Nevus, and Birthmark; and the removal of black or blue tattoos. It is for prescription use only.
This document is a 510(k) Pre-market Notification for a medical device called the "ND:YAG Laser" (Model SL-NY602) from Beijing Superlaser Technology Co., Ltd. It seeks to demonstrate substantial equivalence to a predicate device, the "ND YAG Q-switch Laser Therapy Machine" (K161926) from Beijing ADSS Development Co., Ltd.
Here's an analysis of the provided information regarding acceptance criteria and supporting studies:
1. Table of Acceptance Criteria and Reported Device Performance
Strictly speaking, this document does not present "acceptance criteria" in the traditional sense of specific performance metrics with defined thresholds for sensitivity, specificity, accuracy, etc. Instead, it aims to demonstrate substantial equivalence (SE) based on comparative tables for general, technical, and safety aspects. The "acceptance criteria" for this type of submission are that the proposed device is as safe and effective as the predicate device. The reported performance is implicitly the device meeting the described characteristics.
| Criterion/Metric | Predicated Device K161926 Performance (Implied Acceptance) | Proposed Device ND:YAG Laser Performance | Remark |
|---|---|---|---|
| General | |||
| Product Code | GEX | GEX | SE |
| Regulation No. | 21 CFR 878.4810 | 21 CFR 878.4810 | SE |
| Class | 2 | 2 | SE |
| Where used | hospital | hospital | SE |
| Intended Use | Treatment of benign cutaneous lesions (Warts, Scars, Striae, Psoriasis), benign pigmented lesions (Lentigines, Nevus, Birthmark), and removal of black or blue tattoos. | Treatment of benign cutaneous lesions (Warts, Scars, Striae, Psoriasis), benign pigmented lesions (Lentigines, Nevus, Birthmark), and removal of black or blue tattoos. | SE |
| Technical | |||
| Laser Medium | Nd:YAG | Nd:YAG | SAME |
| Wavelength | 1064 nm, 532 nm | 1064 nm, 532 nm | SAME |
| Output energy | 100-1000mJ (1064nm), 50-500mJ (532nm) | 100-1000mJ (1064nm), 50-500mJ (532nm) | SAME |
| Max. Energy Density | 31.8J/cm2, 15.9 J/cm2 | 31.8J/cm2, 15.9 J/cm2 | SAME |
| Spot Size | 2-10mm | 2-10mm | SAME |
| Pulse Width | 5ns-8ns | 5ns-8ns | DIFFERENT |
| Frequency | 1-10 Hz | 1-10 Hz | SAME |
| Disinfection | Disinfect handpiece by 75% medicinal alcohol | Wipe outer surface with 70% alcohol and non-abrasive medical grade anti-bacterial | SIMILAR (both relate to cleaning/disinfection methods for safety) |
| Laser Class | Class 4 | Class 4 | SAME |
| Aiming Beam | Red Laser, <6mW | Red (650nm) laser, ≤5mW | SAME |
| Safety | |||
| Electrical Safety | Comply with IEC 60601-1, IEC 60601-2-22 | Comply with IEC 60601-1, IEC 60601-2-22 | SE |
| EMC | Comply with IEC 60601-1-2 | Comply with IEC 60601-1-2 | SE |
| Laser Safety | Comply with IEC 60601-2-22, IEC 60825 | Comply with IEC 60601-2-22, IEC 60825 | SE |
2. Sample Size used for the Test Set and the Data Provenance
The submission does not rely on a test set of patient data for clinical performance evaluation. Instead, it relies on demonstrating equivalence through comparison to a legally marketed predicate device and non-clinical testing.
3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications of those Experts
Not applicable. No ground truth was established by experts for a clinical test set in this 510(k) submission.
4. Adjudication Method for the Test Set
Not applicable. There was no clinical test set requiring adjudication in this submission.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. This is a laser device, not an AI-assisted diagnostic or imaging system, so an MRMC study is not relevant.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
Not applicable. This is a laser device, not an algorithm.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)
Not applicable. Clinical ground truth (e.g., pathology, outcomes data) was not used in this 510(k) submission. The "ground truth" for demonstrating substantial equivalence relied on established safety and performance standards for similar laser devices and the characteristics of the predicate device.
8. The sample size for the training set
Not applicable. This is a hardware medical device (laser system), not a machine learning algorithm that requires a training set.
9. How the ground truth for the training set was established
Not applicable, as there is no training set for this type of device.
Ask a specific question about this device
Page 1 of 1